
Living with psoriasis can feel like a long negotiation with your own skin. One month things settle down, the next a patch flares on your elbow or scalp right before an event you had been looking forward to. The itch and the constant covering up can wear you down over time. If creams and light therapy have taken you only so far, you may have heard your doctor mention biologics, a newer class of medicine that has changed the way stubborn cases are managed.
The idea of injecting a medication that acts on your immune system can sound daunting at first, so it helps to understand what these drugs do before deciding anything. This article walks through how biologics work and what to weigh up before starting, so you can have a more confident conversation with your dermatologist.
What biologics are and how they work
Psoriasis is not simply dry skin. It is an immune-driven condition where overactive signals tell skin cells to grow far too quickly, piling up into the thick, scaly plaques you can see and feel. Traditional psoriasis treatment often starts with topical creams and phototherapy, before moving on to immunomodulatory oral medicines that calm the immune system more broadly. Biologics however take a more targeted approach.
Instead of dampening the whole immune system, biologics home in on the specific proteins that drive inflammation in psoriasis, such as TNF-alpha and the interleukins IL-17 and IL-23. By blocking these precise messengers, they interrupt the inflammatory cycle much closer to its source. This precision is why a well-matched psoriasis treatment built around biologics can clear skin substantially while sparing the broader immune response that older systemic drugs tend to affect.
Because they are proteins, biologics cannot be swallowed as a tablet and are given by injection or infusion, either at home or in a clinic. The dosing schedule varies from one biologic to the next, with some given every few weeks and others less often once the initial loading phase is complete. Many people learn to self-inject at home, which cuts down on clinic visits considerably.
Who tends to benefit
These medicines are generally reserved for moderate to severe psoriasis, or for people whose disease keeps returning despite creams and other conventional options. The Dermatological Society of Singapore (2023)1 notes that biologic therapy is considered when standard treatments have fallen short, and the disease is extensive or seriously affects quality of life.
Psoriasis affects roughly 2 to 3 per cent of people worldwide, and at least 40,000 people in Singapore2 live with the condition, so you are far from alone in weighing up your choices. For many people with widespread plaques, biologics offer a level of clearance that creams alone rarely reach, along with a break from the daily routine of managing flares by hand.
Weighing up the benefits
The clinical evidence behind biologics is encouraging. A large meta-analysis found that several of the newer biologics helped a high proportion of patients achieve at least 90 per cent clearance of their psoriasis plaques, with agents such as risankizumab reaching around 79 per cent PASI 90 at longer-term follow-up3. PASI 90 is a common yardstick that means almost completely clear skin, a result that felt out of reach for many patients only a decade ago.
There is good news closer to home, too. A network meta-analysis focused on Asian patients confirmed that biologics deliver similarly high response rates in this group, which is reassuring given how treatment response can vary across populations4. Beyond the skin itself, clearer plaques often bring relief from itch and self-consciousness, and that lift in day-to-day confidence with improvement in quality of life, can be just as meaningful as the physical improvement.
What treatment tends to look like
Starting a biologic is less dramatic than many people expect. After the initial screening and first doses, most of the routine settles into occasional injections and periodic reviews with your dermatologist. Early on, your doctor will monitor how your skin responds and watch for any side effects, then adjust the plan if a particular medicine is not giving the results hoped for. Some people notice their skin calming within a few weeks, while others need a couple of months before the full benefit shows. Patience during this window pays off, since switching too early can mean giving up on a medicine that simply needed more time.
Points to think about before you start
No medicine is a free lunch, and biologics come with practical considerations you will want to discuss openly with your doctor. A few of the main ones include:
- Screening first: Your dermatologist will usually check for hidden infections such as tuberculosis or hepatitis before starting, since biologics affect immune activity.
- Infection risk: Because they modify the immune response, they can slightly raise your susceptibility to certain infections, so any fever or unusual illness should be flagged early.
- Time to work: Some people improve within weeks, while others need a couple of months to see the full effect.
- Ongoing commitment: Biologics manage psoriasis very well but do not cure it, so stopping treatment can allow plaques to return over time.
- Cost and access: These are advanced medicines, so it helps to ask early about pricing and any subsidies or assistance schemes you may qualify for.
Biologics also work best alongside sensible daily habits, and the usual triggers still apply once you are on treatment. If flares tend to follow stress or skin injury for you, a few practical tips for minimising symptoms can sit neatly alongside your medical plan and help you get more out of it.
Conclusion
Choosing whether to start an advanced therapy is a personal call, shaped by how much your skin affects your life and your comfort with regular injections, as well as your general health. A good dermatologist will talk you through the trade-offs honestly and run the right checks before anything begins, helping you set realistic expectations from the start.
If your psoriasis has been holding you back and you would like to understand whether an advanced approach suits you, the team at Angeline Yong Dermatology can assess your skin and review your history, then guide you towards a plan tailored to your needs. Book a consultation today to explore your options and take a confident step towards calmer, clearer skin.
References
Oon, H. H., Tan, C., Aw, D. C. W., Chong, W. S., Koh, H. Y., Leung, Y. Y., Lim, K. S., Pan, J. Y., Tan, E. S., Tan, K. W., Tham, S. N., Theng, C., & Wong, S. N. (2024). 2023 guidelines on the management of psoriasis by the Dermatological Society of Singapore. Annals of the Academy of Medicine, Singapore, 53(9), 562–577. https://doi.org/10.47102/annals-acadmedsg.2023367
Lim, W. L., How, C. H., & Tan, K. W. (2021). Management of psoriasis in primary care. Singapore medical journal, 62(3), 109–112. https://doi.org/10.11622/smedj.2021026
Armstrong, A. W., Puig, L., Joshi, A., Skup, M., Williams, D., Li, J., Betts, K. A., & Augustin, M. (2020). Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis. JAMA dermatology, 156(3), 258–269. https://doi.org/10.1001/jamadermatol.2019.4029
Asahina, A., Fazeli, M. S., Kendall, R., Balasubramanian, G., Serafini, P., Shaikh, A., Gogineni, R., & Zhang, J. (2026). Efficacy of Biologics for the Treatment of Moderate-To-Severe Plaque Psoriasis in the Asian Population: A Systematic Review and Network Meta-Analysis. International journal of dermatology, 65(3), 505–515. https://doi.org/10.1111/ijd.70092


